共 50 条
- [2] MTAP and p16 Immunohistochemistry as Markers for CDKN2A/B Loss in Meningiomas [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 546 - 546
- [4] Comparing loss of p16 and MTAP expression in detecting CDKN2A homozygous deletion in pleomorphic xanthoastrocytoma [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024,
- [6] Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas [J]. Acta Neuropathologica, 2023, 145 : 497 - 500
- [9] Investigating the Use of p16 Immunohistochemistry as a Surrogate Marker for CDKN2A/B Homozygous Deletion in Astrocytomas [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 572 - 573
- [10] Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in higher-grade meningiomas [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (06): : 469 - 470